Novavax: Filed for a Type II Variation of Existing Marketing Authorization With EMA for Jn.1 Covid-19 Vaccine for Individuals Aged 12 and Older
諾瓦瓦克斯醫藥:已向歐洲藥品管理局申請了現有營銷授權的二類變更,針對年齡在12歲及以上個體使用的Jn.1新冠病毒疫苗。
Novavax: Filed for a Type II Variation of Existing Marketing Authorization With EMA for Jn.1 Covid-19 Vaccine for Individuals Aged 12 and Older
諾瓦瓦克斯醫藥:已向歐洲藥品管理局申請了現有營銷授權的二類變更,針對年齡在12歲及以上個體使用的Jn.1新冠病毒疫苗。
譯文內容由第三人軟體翻譯。